Company registration number 09316521 (England and Wales)
KISACO RESEARCH LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
KISACO RESEARCH LIMITED
COMPANY INFORMATION
Directors
G Clayton
S Clayton
M Worden
Company number
09316521
Registered office
41A Maltby Street
Ground Floor
London
SE1 3PA
Auditor
BKL Audit LLP
5 Fleet Place
London
EC4M 7RD
KISACO RESEARCH LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Statement of comprehensive income
8
Statement of financial position
9
Statement of changes in equity
10
Statement of cash flows
11
Notes to the financial statements
12 - 24
KISACO RESEARCH LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 1 -
The directors present the strategic report for the year ended 31 December 2025.
Principal activities
The key aspect of the company's work is organising conferences, summits, and forums that bring together industry professionals, thought leaders, and experts. These events serve as platforms for networking, knowledge sharing, and discussing the latest trends and innovations within the relevant sectors of technology, healthcare, consumer and legal.
The company's conferences often feature keynote speeches, panel discussions, workshops, and exhibitions, allowing participants to gain valuable insights, exchange ideas, and explore business opportunities. The company aims to facilitate meaningful connections and collaborations among industry stakeholders to drive innovation and growth.
Review of the business
Turnover increased from £15.2m to £16.5m, despite reducing the number of conferences by almost half, from 40 to 22. Average revenue per conference increased by 99%, from £368k in 2024 to £732k in 2025 and average employee numbers decreased in the year from 85 to 71. In turn, the profit before tax increased from £1.2m to £2.5m, with an EBITDA margin of 15% (2024 - 8%). Looking to 2026 – more than half of the projected revenue for the year has already been booked, and the company anticipates further improvement in profit margins and other operational metrics throughout the year, including customer retention, average revenue per event and average price points.
Future developments
The company has experienced substantial growth over the past three years and is expecting further growth in 2026. As noted above, a significant proportion of what will become 2026 revenue has been booked in advance. Results thus far have been positive with budgeted targets met. The company will look to increase revenue across all existing streams as well as exploring new opportunities for growth and other efficiencies that will help maintain margins. This includes further reducing the number of events held (from 22 in 2025 to 17 in 2026) to maximise growth and quality of individual events held. The company anticipates increased interest in its conference services as its brand and reputation strengthens.
Principal risks and uncertainties
Foreign exchange risk
The company’s principal foreign currency exposures arise from trading with overseas companies. Company policy permits but does not demand that these exposures may be hedged in order to fix the cost in sterling. This hedging activity involves the use of foreign exchange forward contracts.
Credit risk
The company manages its cash and borrowing requirements in order to maximise interest income and minimise interest expense, whilst ensuring the company has sufficient liquid resources to meet the operating needs of the business.
Liquidity risk
Investments of cash surpluses, borrowings and derivative instruments are made through banks and companies which must fulfil credit rating criteria approved by the Board. All customers who wish to trade on credit terms are subject to credit verification procedures. Trade debtors are monitored on an ongoing basis and provision is made for doubtful debts where necessary.
KISACO RESEARCH LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
Key performance indicators
Our key performance indicators are the satisfaction of our customers and average revenue per event. In 2025, we held 22 different in-person events, with average revenue per event increasing by around 99% year on year. In the future, we aim to continue streamlining our event portfolio and hold fewer, larger events.
The directors are committed to promoting the health, safety and welfare of staff and continue to ensure appropriate measures are undertaken in this regard. No reportable accidents arose during the year or the prior year.
S Clayton
Director
14 May 2026
KISACO RESEARCH LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
The directors present their annual report and financial statements for the year ended 31 December 2025.
Branches
The company has no foreign branches.
Results and dividends
The results for the year are set out on page 8.
Ordinary dividends were paid amounting to £1,103,772 (2024 - £644,451). The directors do not recommend payment of a further dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
G Clayton
S Clayton
M Worden
Auditor
In accordance with the company's articles, a resolution proposing that BKL Audit LLP be reappointed as auditor of the company will be put at a General Meeting.
Statement of directors' responsibilities
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Strategic report
The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of financial risk management.
KISACO RESEARCH LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 4 -
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
S Clayton
Director
14 May 2026
KISACO RESEARCH LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF KISACO RESEARCH LIMITED
- 5 -
Opinion
We have audited the financial statements of Kisaco Research Limited (the 'company') for the year ended 31 December 2025 which comprise the statement of comprehensive income, the statement of financial position, the statement of changes in equity, the statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
KISACO RESEARCH LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF KISACO RESEARCH LIMITED
- 6 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
Capability of the audit detecting irregularities, including fraud
Based on our understanding of the company and industry, we identified that the principal risks of non-compliance with laws and regulations related to the failure to comply with tax regulations, health and safety regulations and anti-bribery and anti-corruption laws, and we considered the extent to which non-compliance might have a material effect on the financial statements. We also considered those laws and regulations that have a direct impact on the preparation of the financial statements such as the Companies Act 2006. We evaluated management's incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls), and determined that the principal risks were related to posting inappropriate journal entries and management bias in accounting estimates. Audit procedures performed by the auditors included:
Discussions with the directors, including consideration of known or suspected instances of noncompliance with laws and regulations and fraud; and
Identifying and testing manual journal entries, in particular any journal entries posted with unclear rationale.
There are inherent limitations in the audit procedures described above, and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example,
forgery or intentional misrepresentations, or through collusion.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
KISACO RESEARCH LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF KISACO RESEARCH LIMITED
- 7 -
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Aron Kleiman FCA
Senior Statutory Auditor
For and on behalf of BKL Audit LLP
19 May 2026
Chartered Accountants and Statutory Auditor
5 Fleet Place
London
EC4M 7RD
KISACO RESEARCH LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2025
- 8 -
2025
2024
Notes
£
£
Revenue
3
16,455,145
15,187,440
Cost of sales
(6,379,197)
(6,009,802)
Gross profit
10,075,948
9,177,638
Administrative expenses
(7,689,360)
(8,043,697)
Operating profit
4
2,386,588
1,133,941
Investment income
7
78,916
84,259
Profit before taxation
2,465,504
1,218,200
Tax on profit
8
(640,529)
(308,248)
Profit for the financial year
1,824,975
909,952
The income statement has been prepared on the basis that all operations are continuing operations.
KISACO RESEARCH LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 DECEMBER 2025
31 December 2025
- 9 -
2025
2024
Notes
£
£
£
£
Non-current assets
Property, plant and equipment
10
97,100
134,376
Current assets
Trade and other receivables
12
11,581,476
6,760,040
Cash and cash equivalents
6,663,176
5,261,823
18,244,652
12,021,863
Current liabilities
13
(16,024,457)
(10,635,538)
Net current assets
2,220,195
1,386,325
Total assets less current liabilities
2,317,295
1,520,701
Non-current liabilities
14
(133,791)
(62,000)
Provisions for liabilities
Deferred tax liability
15
29,200
25,600
(29,200)
(25,600)
Net assets
2,154,304
1,433,101
Equity
Called up share capital
19
1,162
1,250
Share premium account
436,334
436,334
Own shares
20
(932,618)
Retained earnings
21
1,716,808
1,928,135
Total equity
2,154,304
1,433,101
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 14 May 2026 and are signed on its behalf by:
S Clayton
Director
Company registration number 09316521 (England and Wales)
KISACO RESEARCH LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2025
- 10 -
Share capital
Share premium account
Own shares
Retained earnings
Total
Notes
£
£
£
£
£
Balance at 1 January 2024
1,250
436,334
(932,618)
1,662,634
1,167,600
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
-
909,952
909,952
Dividends
9
-
-
-
(644,451)
(644,451)
Balance at 31 December 2024
1,250
436,334
(932,618)
1,928,135
1,433,101
Year ended 31 December 2025:
Profit and total comprehensive income
-
-
-
1,824,975
1,824,975
Dividends
9
-
-
-
(1,103,772)
(1,103,772)
Disposals of own shares
20
-
-
932,618
-
932,618
Reduction of shares
19
(88)
-
(932,530)
(932,618)
Balance at 31 December 2025
1,162
436,334
1,716,808
2,154,304
KISACO RESEARCH LIMITED
STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 11 -
2025
2024
as restated
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
25
2,743,416
2,355,739
Income taxes paid
(295,729)
(210,748)
Net cash inflow from operating activities
2,447,687
2,144,991
Investing activities
Purchase of property, plant and equipment
(22,579)
(73,709)
Interest received
78,916
84,259
Net cash generated from investing activities
56,337
10,550
Financing activities
Movement in derivatives
1,101
97,973
Dividends paid
(1,103,772)
(644,451)
Net cash used in financing activities
(1,102,671)
(546,478)
Net increase in cash and cash equivalents
1,401,353
1,609,063
Cash and cash equivalents at beginning of year
5,261,823
3,652,760
Cash and cash equivalents at end of year
6,663,176
5,261,823
Within the year's financing activities, the company cancelled treasury shares with a brought forward par value of £88 and total value of £932,618. No cash was received nor paid in relation to this cancellation. The statement of changes in equity shows the movement between reserves resulting from this transaction.
Some classifications in the cashflow statement have been adjusted from the manner presented in the prior year. This relates to the presentation of the cash movements in the derivative financial instruments. In particular, the movement in contract liabilities has been split out from the overall movement in payables shown within operating activities. This is now presented alongside the movement in derivate financial instrument assets within financing cashflows.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 12 -
1
Accounting policies
Company information
Kisaco Research Limited is a private company limited by shares incorporated in England and Wales. The registered office is 41A Maltby Street, Ground Floor, London, SE1 3PA.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of certain financial instruments at fair value. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Revenue
Revenue represents amounts receivable from the sale of conference events and corporate sponsorships net of VAT and is recognised on an accruals basis according to the event date, once this can be measured reliably and it is probable that the economic benefits associated with the transactions will flow to the entity. Amounts received prior to the event are recorded within deferred income within current liabilities and released to the profit and loss account once the event has taken place.
1.4
Property, plant and equipment
Property, plant and equipment are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Leasehold improvements
Life of the lease
Fixtures and fittings
5 year straight line basis
Computers
3 year straight line basis
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the statement of income.
1.5
Impairment of non-current assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 13 -
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.6
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including forward foreign exchange contracts are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 14 -
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including trade and other payables are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
Derivatives, including forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 15 -
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or non-current assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 16 -
1.12
Share-based payments
For cash-settled share-based payments, a liability is recognised for the goods and services acquired, measured initially at the fair value of the liability. At the balance sheet date until the liability is settled, and at the date of settlement, the fair value of the liability is remeasured, with any changes in fair value recognised in profit or loss for the year.
Equity-settled share-based payments are measured at fair value at the date of grant by reference to the fair value of the equity instruments granted using the Black-Scholes model. The fair value determined at the grant date is expensed on a straight-line basis over the vesting period, based on the estimate of shares that will eventually vest. A corresponding adjustment is made to equity.
When the terms and conditions of equity-settled share-based payments at the time they were granted are subsequently modified, the fair value of the share-based payment under the original terms and conditions and under the modified terms and conditions are both determined at the date of the modification. Any excess of the modified fair value over the original fair value is recognised over the remaining vesting period in addition to the grant date fair value of the original share-based payment. The share-based payment expense is not adjusted if the modified fair value is less than the original fair value.
Cancellations or settlements (including those resulting from employee redundancies) are treated as an acceleration of vesting and the amount that would have been recognised over the remaining vesting period is recognised immediately.
1.13
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
1.14
Foreign exchange
Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
There are no judgements or key sources of estimation uncertainty requiring specific disclosure.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 17 -
3
Revenue
2025
2024
£
£
Revenue analysed by class of business
Sponsorship revenue
11,768,622
9,557,464
Delegate revenue
4,450,049
5,233,537
Other revenue
236,474
396,439
16,455,145
15,187,440
2025
2024
£
£
Revenue analysed by geographical market
United Kingdom
1,633,937
1,714,413
Europe
2,203,236
2,496,806
Rest of world
12,381,498
10,579,782
No fixed location
236,474
396,439
16,455,145
15,187,440
4
Operating profit
2025
2024
Operating profit for the year is stated after charging:
£
£
Exchange losses
80,900
125,545
Fees payable to the company's auditor for the audit of the company's financial statements
27,600
31,606
Depreciation of owned property, plant and equipment
59,855
66,328
(Profit)/loss on disposal of property, plant and equipment
-
31
Operating lease charges
204,410
205,625
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
71
85
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
5
Employees
(Continued)
- 18 -
Their aggregate remuneration comprised:
2025
2024
£
£
Wages and salaries
5,891,351
6,085,778
Social security costs
807,560
738,409
Pension costs
78,096
89,052
6,777,007
6,913,239
The total amount paid to key management personnel (including directors) in the year was £802,138 (2024 - £922,250).
6
Directors' remuneration
2025
2024
£
£
Remuneration for qualifying services
100,000
130,930
Company pension contributions to defined contribution schemes
1,321
1,321
101,321
132,251
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 1 (2024 - 1).
In addition to the above remuneration for qualifying services, during the year consultancy fees totalling £67,454 (2024 - £53,669) was paid to a director, £89,184 (2024 - £26,765) was paid to the spouse of a director, and £4,864 (2024 - £3,048) was paid to the son of a director.
7
Investment income
2025
2024
£
£
Interest income
Interest on bank deposits
78,916
84,259
2025
2024
Investment income includes the following:
£
£
Interest on financial assets not measured at fair value through profit or loss
78,916
84,259
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 19 -
8
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
636,500
314,200
Adjustments in respect of prior periods
429
(20,952)
Total current tax
636,929
293,248
Deferred tax
Origination and reversal of timing differences
3,600
15,000
Total tax charge
640,529
308,248
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
2,465,504
1,218,200
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
616,376
304,550
Tax effect of expenses that are not deductible in determining taxable profit
10,805
9,252
Adjustments in respect of prior years
(18,900)
Permanent capital allowances in excess of depreciation
12,919
15,398
Under/(over) provided in prior years
429
(2,052)
Taxation charge for the year
640,529
308,248
9
Dividends
2025
2024
£
£
Final paid
1,103,772
644,451
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 20 -
10
Property, plant and equipment
Leasehold improvements
Fixtures and fittings
Computers
Total
£
£
£
£
Cost
At 1 January 2025
146,005
33,622
113,590
293,217
Additions
22,579
22,579
At 31 December 2025
146,005
33,622
136,169
315,796
Depreciation and impairment
At 1 January 2025
41,357
26,508
90,976
158,841
Depreciation charged in the year
41,716
2,733
15,406
59,855
At 31 December 2025
83,073
29,241
106,382
218,696
Carrying amount
At 31 December 2025
62,932
4,381
29,787
97,100
At 31 December 2024
104,648
7,114
22,614
134,376
11
Financial instruments
2025
2024
£
£
Carrying amount of financial assets include:
Instruments measured at fair value through profit or loss
5,686,862
2,966,250
12
Trade and other receivables
2025
2024
Amounts falling due within one year:
£
£
Trade receivables
4,267,991
2,143,733
Derivative financial instruments
5,686,862
2,966,250
Other receivables
78,949
80,824
Prepayments and accrued income
1,547,674
1,569,233
11,581,476
6,760,040
An amount of £78,949 (2024 - £78,949) relates to a deposit receivable at the end of a rental agreement.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 21 -
13
Current liabilities
2025
2024
Notes
£
£
Trade payables
611,012
670,048
Contract liabilities
5,773,936
3,052,223
Corporation tax
636,500
295,300
Other taxation and social security
388,886
560,431
Deferred income
16
8,128,226
5,670,931
Other payables
16,745
13,486
Accruals
469,152
373,119
16,024,457
10,635,538
14
Non-current liabilities
2025
2024
Notes
£
£
Deferred income
16
133,791
62,000
15
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
30,889
27,222
Retirement benefit obligations
(1,689)
(1,622)
29,200
25,600
2025
Movements in the year:
£
Liability at 1 January 2025
25,600
Charge to profit or loss
3,600
Liability at 31 December 2025
29,200
The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 22 -
16
Deferred income
2025
2024
£
£
Deferred income
8,262,017
5,732,931
Included in the financial statements as follows:
Current liabilities
8,128,226
5,670,931
Non-current liabilities
133,791
62,000
8,262,017
5,732,931
17
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
78,096
89,052
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
18
Share-based payment transactions
The entity has share options for certain employees. These grant employees the option of shares to be exercised in the event of a future sale. The number and weighted average price of the options is as follows:
Number of share options
Weighted average exercise price
2025
2024
2025
2024
Number
Number
£
£
Outstanding at 1 January 2025
115,625
115,000
0.89
0.72
Granted
45,625
1.18
Forfeited
1.13
0.75
Outstanding at 31 December 2025
95,000
115,625
0.84
0.89
19
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 0.1p each
1,161,866
1,250,000
1,162
1,250
The ordinary shares rank pari passu and have full voting, dividend and capital distribution rights; they do not confer any rights of redemption.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 23 -
20
Own shares reserve
The treasury share reserve represents amounts paid for by the company in respect of its own shares less the amounts paid to the Company when those shares were sold. During the year the remaining treasury shares were cancelled. No proceeds paid nor received in respect of this cancellation.
21
Retained earnings
The retained earnings reserve represents cumulative profits and losses, net of dividends paid and other adjustments where applicable.
22
Operating lease commitments
As lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
2025
2024
£
£
Within 1 year
204,300
204,300
Years 2-5
109,706
314,006
314,006
518,306
23
Directors' transactions
Dividends totalling £866,272 (2024 - £505,343) were paid in the year in respect of shares held by the company's directors. The remaining dividends amounting to £237,500 (2024 - £139,109) was paid to Penton Learning Systems LLC, a company in which M Worden has a controlling interest.
24
Ultimate controlling party
The controlling party is S Clayton by way of her majority shareholding.
KISACO RESEARCH LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 24 -
25
Cash generated from operations
2025
2024
as restated
£
£
Profit after taxation
1,824,975
909,952
Adjustments for:
Taxation charged
640,529
308,248
Investment income
(78,916)
(84,259)
(Gain)/loss on disposal of property, plant and equipment
-
31
Depreciation and impairment of property, plant and equipment
59,855
66,328
Movements in working capital:
Increase in trade and other receivables
(4,821,436)
(2,425,607)
Movement in derivative assets reclassified to financing activities
2,720,612
1,702,250
Increase in trade and other payables
2,590,424
2,171,292
Movement in derivative liabilities reclassified to financing activities
(2,721,713)
(1,800,223)
Increase in deferred income
2,529,086
1,507,727
Cash generated from operations
2,743,416
2,355,739
26
Analysis of changes in net funds
1 January 2025
Cash flows
31 December 2025
£
£
£
Cash at bank and in hand
5,261,823
1,401,353
6,663,176
2025-12-312025-01-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100G ClaytonS ClaytonM Worden093165212025-01-012025-12-3109316521bus:Director12025-01-012025-12-3109316521bus:Director22025-01-012025-12-3109316521bus:Director32025-01-012025-12-3109316521bus:RegisteredOffice2025-01-012025-12-31093165212025-12-31093165212024-01-012024-12-3109316521core:RetainedEarningsAccumulatedLosses2024-01-012024-12-3109316521core:RetainedEarningsAccumulatedLosses2025-01-012025-12-31093165212024-12-3109316521core:LeaseholdImprovements2025-12-3109316521core:FurnitureFittings2025-12-3109316521core:ComputerEquipment2025-12-3109316521core:LeaseholdImprovements2024-12-3109316521core:FurnitureFittings2024-12-3109316521core:ComputerEquipment2024-12-3109316521core:WithinOneYear2025-12-3109316521core:WithinOneYear2024-12-3109316521core:AfterOneYear2025-12-3109316521core:AfterOneYear2024-12-3109316521core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3109316521core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3109316521core:ShareCapital2025-12-3109316521core:ShareCapital2024-12-3109316521core:SharePremium2025-12-3109316521core:SharePremium2024-12-3109316521core:OtherMiscellaneousReserve2025-12-3109316521core:OtherMiscellaneousReserve2024-12-3109316521core:RetainedEarningsAccumulatedLosses2025-12-3109316521core:RetainedEarningsAccumulatedLosses2024-12-3109316521core:ShareCapital2023-12-3109316521core:SharePremium2023-12-3109316521core:TreasurySharesOwnSharesReserve2023-12-3109316521core:RetainedEarningsAccumulatedLosses2023-12-31093165212023-12-3109316521core:TreasurySharesOwnSharesReserve2024-12-3109316521core:TreasurySharesOwnSharesReserve2025-12-3109316521core:ShareCapitalOrdinaryShareClass12025-12-3109316521core:ShareCapitalOrdinaryShareClass12024-12-3109316521core:ShareCapital2025-01-012025-12-3109316521core:SharePremium2025-01-012025-12-31093165212024-12-3109316521core:LeaseholdImprovements2025-01-012025-12-3109316521core:FurnitureFittings2025-01-012025-12-3109316521core:ComputerEquipment2025-01-012025-12-3109316521core:UKTax2025-01-012025-12-3109316521core:UKTax2024-01-012024-12-310931652112025-01-012025-12-310931652112024-01-012024-12-3109316521core:LeaseholdImprovements2024-12-3109316521core:FurnitureFittings2024-12-3109316521core:ComputerEquipment2024-12-3109316521core:CurrentFinancialInstruments2025-12-3109316521core:CurrentFinancialInstruments2024-12-3109316521core:CurrentFinancialInstrumentscore:WithinOneYear12025-12-3109316521core:CurrentFinancialInstrumentscore:WithinOneYear12024-12-3109316521core:Non-currentFinancialInstruments2025-12-3109316521core:Non-currentFinancialInstruments2024-12-3109316521bus:OrdinaryShareClass12025-01-012025-12-3109316521bus:OrdinaryShareClass12025-12-3109316521bus:OrdinaryShareClass12024-12-3109316521core:BetweenTwoFiveYears2025-12-3109316521core:BetweenTwoFiveYears2024-12-3109316521bus:PrivateLimitedCompanyLtd2025-01-012025-12-3109316521bus:FRS1022025-01-012025-12-3109316521bus:Audited2025-01-012025-12-3109316521bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP